Antonius Schuh - Net Worth and Insider Trading
Antonius Schuh Net Worth
The estimated net worth of Antonius Schuh is at least $703 dollars as of 2024-09-20. Antonius Schuh is the CEO of Cardiff Oncology Inc and owns about 278 shares of Cardiff Oncology Inc (CRDF) stock worth over $703. Details can be seen in Antonius Schuh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Antonius Schuh has not made any transactions after 2015-08-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Antonius Schuh
Antonius Schuh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Antonius Schuh owns 4 companies in total, including Cardiff Oncology Inc (CRDF) , Precipio Inc (PRPO) , and Sorrento Therapeutics Inc (SRNE) among others .
Click here to see the complete history of Antonius Schuh’s form 4 insider trades.
Insider Ownership Summary of Antonius Schuh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRDF | Cardiff Oncology Inc | 2015-08-12 | director & CEO |
| PRPO | Precipio Inc | 2009-05-20 | director |
| SRNE | Sorrento Therapeutics Inc | 2010-02-16 | director & 10 percent owner & Chairman and CEO |
 | | 2003-10-28 | director & President and CEO |
Antonius Schuh Latest Holdings Summary
Antonius Schuh currently owns a total of 1 stock. Antonius Schuh owns 278 shares of Cardiff Oncology Inc (CRDF) as of August 12, 2015, with a value of $703.
Latest Holdings of Antonius Schuh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRDF | Cardiff Oncology Inc | 2015-08-12 | 278 | 2.53 | 703 |
Holding Weightings of Antonius Schuh
Antonius Schuh Form 4 Trading Tracker
According to the SEC Form 4 filings, Antonius Schuh has made a total of 0 transactions in Cardiff Oncology Inc (CRDF) over the past 5 years. The most-recent trade in Cardiff Oncology Inc is the acquisition of 278 shares on August 12, 2015, which cost Antonius Schuh around $109,000.
Insider Trading History of Antonius Schuh
- 1
Antonius Schuh Trading Performance
GuruFocus tracks the stock performance after each of Antonius Schuh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Antonius Schuh is -17.26%. GuruFocus also compares Antonius Schuh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Antonius Schuh within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Antonius Schuh's insider trading performs compared to the benchmark.
Performance of Antonius Schuh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.65 | | | | | |
| Relative Return to S&P 500(%) | 6.64 | | | | | |
Antonius Schuh Ownership Network
Antonius Schuh Owned Company Details
What does Cardiff Oncology Inc do?
Who are the key executives at Cardiff Oncology Inc?
Antonius Schuh is the director & CEO of Cardiff Oncology Inc. Other key executives at Cardiff Oncology Inc include Chief Medical Officer Fairooz Kabbinavar , Chief Scientific Officer Mark Erlander , and Chief Financial Officer James E. Levine .
Cardiff Oncology Inc (CRDF) Insider Trades Summary
Over the past 18 months, Antonius Schuh made no insider transaction in Cardiff Oncology Inc (CRDF). Other recent insider transactions involving Cardiff Oncology Inc (CRDF) include a net purchase of 52,950 shares made by Gary W Pace ,
In summary, during the past 3 months, insiders sold 0 shares of Cardiff Oncology Inc (CRDF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiff Oncology Inc (CRDF) were sold and 52,950 shares were bought by its insiders, resulting in a net purchase of 52,950 shares.
Cardiff Oncology Inc (CRDF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cardiff Oncology Inc Insider Transactions
Antonius Schuh Mailing Address
Above is the net worth, insider trading, and ownership report for Antonius Schuh. Currently GuruFocus does not have mailing address information for Antonius Schuh.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
